Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
and glycosylations. These are essential for calcium binding and food functionalities of caseins. We are looking for an expert in mass-spectrometry based proteomics who will work alongside our
-
position is available in Dr. Gustavo Silva’s laboratory at Duke University (https://sites.duke.edu/silvalab ). The prospective candidate will develop research focused on developing and using functional
-
1 Apr 2026 Job Information Organisation/Company University of Rijeka Faculty of Medicine Department Center for Proteomics Research Field Chemistry » Biochemistry Medical sciences » Veterinary
-
1 Apr 2026 Job Information Organisation/Company University of Rijeka Faculty of Medicine Department Center for Proteomics Research Field Chemistry » Biochemistry Medical sciences » Veterinary
-
website: https://cruchagalab.wustl.edu/ . Research Projects: Plasma, CSF and Brain Proteomic analysis. Biomarker identification through the use of machine learning and AI approaches. Integration
-
Project Description We invite applications for a postdoctoral position in experimental mass spectrometry-based proteomics, focused on peptide ionization, charge state behavior, and fragmentation
-
PhD Position in Method Development for Peptide Ionization and Fragmentation_3590 Project Description We invite applications for a fully funded PhD position in experimental proteomics. The successful
-
of colorectal cancer (CRC) using organoid models. The researcher will focus on integrating dynamic mutations, live multiplexed transcriptomic imaging, and proteomic imaging at the cellular level to predict
-
on the genome and on downstream mechanistic function, Holstege and her team use advanced omics technologies, including single cell transcriptomics, long read sequencing, proteomics, and others. About the role
-
on acoustofluidic cell sorting and proteomics. This project focuses on cell separation and isolation followed by investigation of proteomic alterations in isolated circulating tumour cells (CTCs) from cancer patients